查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576973

睡眠补助的全球市场的按评估:各产品，睡眠障碍，各地区，机会，预测(2017年～2031年)

Sleep Aids Market Assessment, By Product, By Sleep Disorder, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 246 Pages | 商品交期: 3-5个工作天内

价格

全球睡眠辅助市场规模预计将从 2023 年的 818 亿美元增至 2031 年的 1349.7 亿美元，在 2024-2031 年的预测期内复合年增长率为 6.46%。由于睡眠障碍患者数量的增加、与睡眠障碍相关的研发活动的增加以及人们对深度睡眠及其健康影响的认识不断提高，预计该市场将以更快的速度增长。

改善个人睡眠并缓解失眠、睡眠呼吸中止症和不宁腿症候群等睡眠障碍的产品称为助眠剂。这些选择包括处方药、非处方补充剂、草药以及睡眠追踪设备和智慧床垫等新技术。近年来，助眠剂的需求急剧增加。这是由于睡眠作为健康和福祉的基本要素的需求不断增加。压力增加、忙碌的生活方式以及科技设备的普及也会扰乱睡眠。随着睡眠不足对健康的负面影响越来越明显，越来越多的人开始寻求自然疗法来解决这个问题。大流行加剧了这些需求，许多人的焦虑程度和睡眠问题加剧。这种情况促使顾客寻求治疗，同时也加大了医疗专业人员推荐助眠剂的压力。随着越来越多的人患有精神疾病、产品创新不断增加以及对精神健康问题的容忍度不断提高，睡眠辅助市场持续增长，引起了消费者和企业的极大兴趣。

2023 年 5 月，专注于改造药物以改善生活的生物製药公司 Avadel Pharmaceuticals plc 宣布，美国食品药物管理局 (FDA) 已最终批准 LUMRYZ。 LUMRYZ 是一种羟丁酸钠缓释製剂，旨在睡前服用一次，用于治疗成人发作性睡病患者的猝倒或日间过度嗜睡 (EDS)。这项最终批准使 LUMRYZ 成为 FDA 批准的第一个也是唯一一个睡前一次用于发作性睡病患者的羟丁酯。此外，LUMRYZ 也获得 FDA 授予的孤儿药独家权利。

本报告研究和分析了全球睡眠辅助市场，提供市场规模和预测、市场动态以及主要参与者的状况。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 全球睡眠补助市场预测(2017年～2031年)

  • 市场规模的分析与预测
    • 金额
  • 市场占有率的分析与预测
    • 各产品
    • 各睡眠障碍
    • 各地区
    • 市场占有率分析:各企业(金额)(前五名公司和其他 - 2023年)
  • 市场地图分析(2023年)
    • 各产品
    • 各睡眠障碍
    • 各终端用户
    • 各地区

第5章 北美的睡眠补助市场预测(2017年～2031年)

  • 市场规模的分析与预测
    • 金额
  • 市场占有率的分析与预测
    • 各产品
    • 各睡眠障碍
    • 占有率:各国
  • 各国的市场评估
    • 美国的睡眠补助市场预测(2017年～2031年)
    • 加拿大
    • 墨西哥

第6章 欧洲的睡眠补助市场预测(2017年～2031年)

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第7章 亚太地区的睡眠补助市场预测(2017年～2031年)

  • 印度
  • 中国
  • 日本
  • 澳洲
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第8章 南美的睡眠补助市场预测(2017年～2031年)

  • 巴西
  • 阿根廷

第9章 中东·非洲的睡眠补助市场预测(2017年～2031年)

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第10章 供需分析

第11章 进口和出口的分析

第12章 价值链分析

第13章 波特的五力分析

第14章 大环境分析

第15章 价格分析

第16章 市场动态

  • 推动市场要素
  • 市场课题

第17章 市场趋势与发展

第18章 法规结构和革新

  • 临床试验
  • 法规当局的认证

第19章 专利形势

第20章 案例研究

第21章 竞争情形

  • 前五名市场领导者的竞争矩阵
  • 前五名公司的SWOT分析
  • 前十大主要企业的形势
    • BMC Medical Co., Ltd.
    • Cadwell Industries, Inc.
    • Compumedics Limited
    • Fisher & Paykel Healthcare Limited
    • Merck& Co., Inc.
    • Natus Medical Inc.
    • Koninklijke Philips N.V.
    • Pfizer Inc.
    • Sanofi S.A.
    • SleepMed Inc.

第22章 策略性推荐

第23章 本公司相关资料，免责声明

Product Code: MX12169

Global sleep aids market is projected to witness a CAGR of 6.46% during the forecast period 2024-2031, growing from USD 81.80 billion in 2023 to USD 134.97 billion in 2031. The market for sleep aids is anticipated to grow at a faster pace under the influence of rising cases of sleep disorders, increased R&D initiatives around sleep disorders, and heightened awareness about sound sleep and its health implications.

Products that help individuals sleep better and mitigate sleep disorders, including insomnia, sleep apnea, and restless leg syndrome, are referred to as sleep aids. This option includes prescription medications, over-the-counter supplements, herbal remedies, and newer technologies such as a sleep-tracking device and smart mattresses. Sleep aids have experienced a highly increasing demand in recent years, heralded by the very awareness of the increasing need for sleep as an integral part of health and wellbeing. Increased stress levels, busy lifestyles, and widespread influences of technological gadgets have also contributed to disturbances in sleep. As the ill effects of sleep deprivation on health become more and more apparent, increasingly more individuals seek natural remedies to eliminate this issue. The pandemic has further fueled these rising needs, with many people experiencing heightened anxiety levels and disturbances in their sleep. These conditions made customers seek a cure, and at the same time, increased pressure on healthcare professionals to recommend sleep aids. As more and more people come forward to discuss mental disorders, product innovation, and increased tolerance toward mental health issues, the sleep aid market continues to gain momentum, thus bringing significant interest to both consumer groups and businesses.

In May 2023, Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to improve lives, announced that the U.S. Food & Drug Administration (FDA) has granted final approval to LUMRYZ. LUMRYZ is an extended-release formulation of sodium oxybate intended to be taken once at bedtime for treating cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. With this final approval, LUMRYZ becomes the first and only FDA-approved once-at-bedtime oxybate for people living with narcolepsy. Additionally, LUMRYZ has been granted Orphan Drug Exclusivity by the FDA.

Rising Sleep Troubles Among People to Boost Market Demand

The growing incidence of sleeping disorders is generating high demand for sleep aids all over the world. There are several reasons for this. The elderly population is more prone to sleeping problems, and the related customer base is huge. Other factors for the increase of sleep disorders including modern lifestyle are stress levels, irregular work hours, and increased time in front of screens, which have disrupted normal sleep cycles in almost all the strata of the population. Public awareness of the need for sleep for overall health leads people to seek effective solutions further and thus increases market demand. Improving technology in sleeping aids, such as wearable devices and smart beds, also upgrades the product offerings and attracts consumers. According to the data of the National Council of Aging, around 39 million adults in the United States suffer from obstructive sleep apnea (OSA) and the number goes up to 936 million adults around the world who have mild to severe OSA. Snoring is a common symptom of sleep apnea in up to 94% of patients.

Growing Focus on R&D for Sleeping Aids to Bring Market Growth

The growth in R&D for sleep aids is expected to propel the market forward. As the issues relating to sleep, such as sleep apnea and insomnia, are increasing, there is a greater demand for a better solution. R&D initiatives have also led to the manufacturing of unique products, natural supplements, and sophisticated sleep technologies, catering to the diverse needs of the consumer. Companies, as well as startup firms, invest heavily in R&D, exploring various new compounds, formulations, as well as delivery methods, that can better improve the quality of sleep without adverse effects. Such products are validated through clinical trials and scientific studies, while consumer confidence generated by those studies boosts adoption. For instance, in July 2024, Corundum Neuroscience awarded a research grant to Tel Aviv University to develop a machine learning-based method for the non-invasive detection of abnormal brain activity in deep brain regions during sleep. The project aims to identify brain activity linked to dementia using high-density EEG. The goal is to create disease-specific biomarkers for neurodegenerative conditions and improve diagnostics and treatment.

Insomnia Segment to Dominate the Market

The insomnia market segment is expected to lead the sleep aid market, as sleeping disorders are on the rise and more people become aware of their health implications. The rising insomnia rates due to stress, anxiety, and lifestyle issues keep more people searching for a healthy solution that would provide them with better quality sleep. Such chronic insomnia affects a large portion of the population, and thus the demand for specialty products, such as prescription medications, over-the-counter supplements, or natural remedies is high. The emergence of new, insomnia-specific formulations and products is also on the rise, enhancing effectiveness and consumer acceptability. Strategic product launches for insomnia treatment further increase its market share, for instance, in July 2024, Jiangsu Simcere Pharmaceutical Co., Ltd. announced that the National Medical Products Administration has accepted the new drug application for Quviviq (daridorexant hydrochloride tablets), an innovative anti-insomnia drug developed in collaboration with Idorsia of Switzerland. Quviviq is a dual orexin receptor antagonist (DORA) and represents a new generation of anti-insomnia drugs. The drug has been approved for marketing in nine countries, including the United States, the United Kingdom, Switzerland, and Canada.

North America Dominates Sleep Aids Market

North America highly dominates the market for sleep aids. Several interrelated factors have placed the region at the top. The first reason is that North America, combined with lifestyle stressors, displays one of the highest rates of sleep disorders, especially insomnia and sleep apnea. Increased screen time and fast-paced work culture have led to this rising prevalence, increasing consumer awareness and demand for effective solutions to sleep issues. Advanced healthcare infrastructure and significant investments in research and development characterize North America as well. The majors, as well as startups, always are innovation and product launch leaders as they develop new sleep aids, prescription as well as over-the-counter formulations for consumers to avail. Culturally, it is pushing further the market with health and wellness awareness that more consumers are eager to find natural and holistic remedies besides pharmaceuticals.

Future Market Scenario (2024-2031F)

Smart mattresses equipped with AI integration are poised to drive significant growth in the sleep aids market. These innovative products utilize advanced sensors to monitor sleep patterns, heart rates, and breathing, providing real-time feedback and personalized sleep recommendations. By adjusting firmness, temperature, and support based on individual needs, smart mattresses enhance overall sleep quality. Furthermore, AI-driven insights can help users understand their sleep behavior, encouraging healthier habits. As consumers increasingly seek personalized and tech-driven solutions to improve sleep, the demand for smart mattresses is expected to rise, positioning them as key players in the evolving sleep aids market. In November 2023, DeRUCCI Group launched the T11 Pro Smart Mattress, the first AIoT smart mattress, designed to enhance sleep quality through advanced technology. It features 23 AI sensors that monitor various health metrics, including body temperature and heart rate, and 18 support airbags that adjust to users' movements. The mattress utilizes a patented algorithm for real-time adjustments tailored to individual sleeping positions, improving spinal health by over 40%. It connects with IoT devices for a fully integrated smart bedroom experience and offers features like snoring intervention and personalized sleep reports.

Key Players Landscape and Outlook

The sleep aid market features a dynamic landscape dominated by key players across pharmaceuticals, supplements, and technology sectors. Prominent pharmaceutical companies, such as Pfizer and Merck, offer prescription medications like Zolpidem and Eszopiclone, focusing on effectiveness and safety to address chronic insomnia. Over-the-counter brands like Unisom and Tylenol cater to consumers seeking immediate relief with accessible solutions. Recent activities in the sleep aids market include regulatory approvals and joint ventures for market expansion.

In March 2024, Vanda Pharmaceuticals Inc. announced that it received a Complete Response Letter (CRL) from the United States Food and Drug Administration (FDA) as part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ (tasimelteon) in the treatment of insomnia characterized by difficulties with sleep initiation.

In October 2023, Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and other sleep disorders, announced a new joint venture with Shionogi & Co., Ltd., a leading global research-driven pharmaceutical company based in Japan. The joint venture, called Shionogi-Apnimed Sleep Science, LLC, will initially focus on accelerating the discovery, preclinical, and clinical development of novel pharmacologic solutions designed to address the complex pathology of OSA.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Sleep Aids Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Mattresses and Pillows
      • 4.2.1.2. Sleep Laboratory Services
      • 4.2.1.3. Medication
      • 4.2.1.4. Others
    • 4.2.2. By Sleep Disorder
      • 4.2.2.1. Insomnia
      • 4.2.2.2. Sleep Apnea
      • 4.2.2.3. Restless Legs Syndrome
      • 4.2.2.4. Narcolepsy
      • 4.2.2.5. Sleepwalking
      • 4.2.2.6. Other Sleep Disorders
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia-Pacific
      • 4.2.3.4. South America
      • 4.2.3.5. Middle East and Africa
    • 4.2.4. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Sleep Disorder
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North America Sleep Aids Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Mattresses and Pillows
      • 5.2.1.2. Sleep Laboratory Services
      • 5.2.1.3. Medication
      • 5.2.1.4. Others
    • 5.2.2. By Sleep Disorder
      • 5.2.2.1. Insomnia
      • 5.2.2.2. Sleep Apnea
      • 5.2.2.3. Restless Legs Syndrome
      • 5.2.2.4. Narcolepsy
      • 5.2.2.5. Sleepwalking
      • 5.2.2.6. Other Sleep Disorders
    • 5.2.3. By Country Share
      • 5.2.3.1. United States
      • 5.2.3.2. Canada
      • 5.2.3.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Sleep Aids Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Mattresses and Pillows
          • 5.3.1.2.1.2. Sleep Laboratory Services
          • 5.3.1.2.1.3. Medication
          • 5.3.1.2.1.4. Others
        • 5.3.1.2.2. By Sleep Disorder
          • 5.3.1.2.2.1. Insomnia
          • 5.3.1.2.2.2. Sleep Apnea
          • 5.3.1.2.2.3. Restless Legs Syndrome
          • 5.3.1.2.2.4. Narcolepsy
          • 5.3.1.2.2.5. Sleepwalking
          • 5.3.1.2.2.6. Other Sleep Disorders
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Sleep Aids Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Sleep Aids Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Sleep Aids Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Sleep Aids Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. BMC Medical Co., Ltd.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Cadwell Industries, Inc.
    • 21.3.3. Compumedics Limited
    • 21.3.4. Fisher & Paykel Healthcare Limited
    • 21.3.5. Merck& Co., Inc.
    • 21.3.6. Natus Medical Inc.
    • 21.3.7. Koninklijke Philips N.V.
    • 21.3.8. Pfizer Inc.
    • 21.3.9. Sanofi S.A.
    • 21.3.10. SleepMed Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 3. Global Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 4. Global Sleep Aids Market Share (%), By Region, 2017-2031F
  • Figure 5. North America Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 6. North America Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 7. North America Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 8. North America Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 9. United States Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. United States Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 11. United States Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 12. Canada Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 13. Canada Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 14. Canada Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 15. Mexico Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Mexico Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 17. Mexico Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 18. Europe Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Europe Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 20. Europe Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 21. Europe Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 22. Germany Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 23. Germany Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 24. Germany Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 25. France Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 26. France Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 27. France Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 28. Italy Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Italy Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 30. Italy Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 31. United Kingdom Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. United Kingdom Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 33. United Kingdom Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 34. Russia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Russia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 36. Russia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 37. Netherlands Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 38. Netherlands Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 39. Netherlands Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 40. Spain Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Spain Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 42. Spain Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 43. Turkey Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Turkey Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 45. Turkey Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 46. Poland Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Poland Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 48. Poland Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 49. South America Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. South America Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 51. South America Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 52. South America Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 53. Brazil Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. Brazil Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 55. Brazil Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 56. Argentina Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Argentina Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 58. Argentina Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 59. Asia-Pacific Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Asia-Pacific Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 61. Asia-Pacific Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 62. Asia-Pacific Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 63. India Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 64. India Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 65. India Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 66. China Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 67. China Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 68. China Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 69. Japan Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Japan Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 71. Japan Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 72. Australia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 73. Australia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 74. Australia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 75. Vietnam Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 76. Vietnam Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 77. Vietnam Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 78. South Korea Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 79. South Korea Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 80. South Korea Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 81. Indonesia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Indonesia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 83. Indonesia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 84. Philippines Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Philippines Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 86. Philippines Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 87. Middle East & Africa Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 88. Middle East & Africa Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 89. Middle East & Africa Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 90. Middle East & Africa Sleep Aids Market Share (%), By Country, 2017-2031F
  • Figure 91. Saudi Arabia Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 92. Saudi Arabia Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 93. Saudi Arabia Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 94. UAE Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. UAE Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 96. UAE Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 97. South Africa Sleep Aids Market, By Value, In USD Billion, 2017-2031F
  • Figure 98. South Africa Sleep Aids Market Share (%), By Product, 2017-2031F
  • Figure 99. South Africa Sleep Aids Market Share (%), By Sleep Disorder, 2017-2031F
  • Figure 100. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 101. By Sleep Disorder Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 102. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023